Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_assertion description "[At the lowest doses, the TGFbeta-RII-mutated and KRAS2-mutated cell line, TOV-21G, and the BRCA2-mutated cell line, TOV-81D, demonstrated a significantly higher sensitivity to cisplatin and gamma-irradiation than the TP53-mutated cell lines, TOV-112D and OV-90.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_assertion evidence source_evidence_literature NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_assertion SIO_000772 15258697 NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_assertion wasDerivedFrom befree-20150227 NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_assertion wasGeneratedBy ECO_0000203 NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP273678.RAfXdv7HoKELHv-8YxwPnwT-bbU3EwoA3ZywX4W6-mVoc130_provenance.